- Anixa Biosciences announced developments regarding its CER-T cancer treatment, collaborating with Cleveland Clinic, at a conference in New York City on September 2, 2025.
- Anixa Biosciences and Cleveland Clinic are developing a vaccine portfolio and ovarian cancer immunotherapy program.
Anixa Biosciences and Cleveland Clinic are collaborating on a vaccine development program, which is now supported by the U.S. Department of Defense.
3 reports, 1 independent
Updated Sep 11
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Anixa Biosciences and Cleveland Clinic are collaborating on a vaccine development program, which is now supported by the U.S. Department of Defense.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cleveland Clinic
nonprofit multispecialty academic medical center based in Cleveland, Ohio, United States